Trials / Completed
CompletedNCT04649255
Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)
Liquid Embolization of Arterial Hemorrhages in the Peripheral Vasculature: The LAVA Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 113 (actual)
- Sponsor
- BlackSwan Vascular, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and effectiveness of the Lava LES for the embolic treatment of arterial hemorrhage in the peripheral vasculature.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Liquid Embolic | Lava Liquid Embolic System (LES) |
Timeline
- Start date
- 2021-04-14
- Primary completion
- 2022-08-17
- Completion
- 2022-08-17
- First posted
- 2020-12-02
- Last updated
- 2024-04-12
- Results posted
- 2024-04-12
Locations
9 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04649255. Inclusion in this directory is not an endorsement.